Investors

SciFluor Life Sciences launched in February 2011 with a $5 million funding commitment from Allied Minds. Allied Minds is a private investment firm that deploys capital to form, fund, manage and build companies based on market-creating technologies developed at renowned U.S. universities and federal research institutions. More information about the Boston-based company can be found at www.alliedminds.com

SciFluor News

SciFluor Life Sciences Awarded U.S. Patent for Integrin αvβ3 Inhibitors Designed for the Topical Treatment of Retinal Disease
read more >

SciFluor Presents Update on Novel KCNQ2/3 activator at Epilepsy Pipeline Conference
read more >

SciFluor Life Sciences Presents New Preclinical Data Highlighting Lead Program as a More Potent and Selective Treatment for Partial-Onset Seizure
read more >